Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-week randomized double-blind trial of inhaled AZD3199 vs formoterol vs placebo in COPD
jRCT2080220766Phase 2
- Sponsor
- AstraZeneca
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AZD3199 in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by AstraZeneca.
02
Drugs
AZD3199
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCT2080220766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220766.